• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: EDWARDS LIFESCIENCES EDWARDS COMMANDER DELIVERY; AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIVERED

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

EDWARDS LIFESCIENCES EDWARDS COMMANDER DELIVERY; AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIVERED Back to Search Results
Model Number 9600LDS29A
Device Problem Physical Resistance/Sticking (4012)
Patient Problem Unspecified Vascular Problem (4441)
Event Date 07/29/2022
Event Type  Injury  
Manufacturer Narrative
Investigation is ongoing.
 
Event Description
As reported by field clinical specialist, a patient underwent a percutaneous transfemoral tavr procedure with a 29mm sapien 3 ultra valve in the aortic position.During the procedure, they lost wire access in the left ventricle and decided to remove the entire system.However, during withdrawal, the sheath was pulled back outside the vessel prior to the delivery system removal.They felt there was a vascular injury.Hemostat was used for blunt dissection of the subcutaneous tissue for removal of the system.Per follow-up, the team advised that the commander delivery system may have caught on the vessel during removal resulting in the vascular injury.The sheath was replaced and upsized to a non-edwards sheath.A new system was prepped in normal fashion.The valve was advanced through the non-edwards sheath without incident and deployed as intended and without complication.The patient was being seen by a vascular surgeon for common femoral repair and was in stable condition.
 
Manufacturer Narrative
A supplemental mdr is being submitted due to engineering evaluation findings.Sections b4, g3, g6, h2, h6: type of investigation, investigation findings, investigation conclusions and h10 has been updated.The device was not returned to edwards lifesciences for evaluation.A review of edwards lifesciences risk management documentation was performed for this case.The reported event is an anticipated risk of the transcatheter heart valve procedure, additional assessment of this event is not required at this time.The complaint for difficulty or inability to withdraw system with valve through sheath was unable to be confirmed.As the device was not returned, engineering was unable to perform any visual inspection, functional testing, or dimensional analysis.Therefore, the presence of a manufacturing non-conformance was unable to be determined.A review of ifu/training materials revealed no deficiencies.Furthermore, no abnormalities were reported during device unpacking or preparation.Per complaint description, -during the procedure, they lost wire access in the left ventricle and decided to remove the entire system.However, during withdrawal, the sheath was pulled back outside the vessel prior to getting the delivery system into the sheath.They felt there was a vascular injury.Hemostat was used for blunt dissection of the subcutaneous tissue for removal of the system.Per follow-up, the team advised that the commander delivery system may have caught on the vessel during removal resulting in the vascular injury.- 3mensio of patient anatomy was provided and showed no abnormal or severe degree of tortuosity or calcification.Per training manual, -withdraw the delivery system and sheath as a single unit completely from the arteriotomy while maintaining guidewire position.- if the sheath is not removed as a unit with the delivery system and valve, the struts of the valve can be exposed to the vasculature and potentially catch onto the patient-s anatomy when attempting remove the delivery system, as what was reported.Available information suggests that procedural factors (inadvertently removing only the sheath) may have contributed to the complaint event.A definitive root cause is unable to be determined.No ifu/labeling/training manual inadequacies were identified.Therefore, no corrective or preventative action nor pra is required at this time.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EDWARDS COMMANDER DELIVERY
Type of Device
AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIVERED
Manufacturer (Section D)
EDWARDS LIFESCIENCES
1 edwards way
irvine CA 92614
Manufacturer (Section G)
EDWARDS LIFESCIENCES
1 edwards way
irvine CA 92614
Manufacturer Contact
renee van dorne
1 edwards way
irvine, CA 92614
9492506385
MDR Report Key15287610
MDR Text Key298561495
Report Number2015691-2022-07494
Device Sequence Number1
Product Code NPT
UDI-Device Identifier00690103193961
UDI-Public(01)00690103193961(17)231124(10)64121121
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P140031
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date 10/14/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date11/24/2023
Device Model Number9600LDS29A
Device Catalogue Number9600LDS29A
Device Lot Number64121121
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 07/29/2022
Initial Date FDA Received08/24/2022
Supplement Dates Manufacturer Received09/09/2022
10/13/2022
Supplement Dates FDA Received10/04/2022
10/14/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured11/24/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age78 YR
Patient SexMale
-
-